CTRI/2020/05/025295招募中未知
Effect of Ayurvedic Nootropics On Cognitive Function in Breast Cancer patients on Adjuvant Chemotherapy A Randomized Controlled Trial
Department of AYUSH Extramural Research Scheme Govt of India0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Early stage II and III breast cancer patients
- •2. Age between 18 to 75 years
- •3. Scheduled to undergo at least 6 cycles of adjuvant chemotherapy followed by
- •adjuvant radiotherapy at HCG hospital.
- •4. High school education with ability to read and write English
排除标准
- •1. Those with prior h/o depression, major psychiatric illness and Alzheimerâ??s
- •disease and on medication
- •2. Those with brain metastases
- •3. Concurrent medical condition likely to influence survival
- •4. Uncontrolled diabetes, hypertension and autoimmune disease
- •5. Neurological disorders such as any significant head injury, epilepsy, Parkinsonâ??s
- •disease, neurodegenerative disorders etc.
- •6. Regular participation in an active behavioral intervention/Ayurveda Nootropic in
- •the last six months
- •7. H/o recent infections or fever in the past two weeks
- •8. Those with anemia (Hemoglobin < 10gm %)
- •9. Those with cardiac pacemakers or other incompatible body implants (For f MRI
- •10. Left handedness or mixed handedness
- •11. Claustrophobia
研究者
相似试验
尚未招募
不适用
Defining a relationship between ayurvedic medicines containing heavy metals and final stage of chronic kidney diseaseCTRI/2021/10/037229ICMR
尚未招募
2 期
A Clinical study to find the add-On Effect of Selected Ayurvedic Treatment Protocol in Focal Seizures Evolving to Generalized SeizuresCTRI/2021/01/030168I
招募中
2 期
EFFECT OF AYURVEDIC CODED DRUG (AYUSH MANAS) IN THE MANAGEMENT OF MANASAMANDATA (MENTAL RETARDATION)CTRI/2011/04/001701Central Council for Research in Ayurveda and Siddha CCRAS120
尚未招募
3 期
A clinical trial to study the effect of Ayurvedic treatment in PsoriasisCTRI/2020/11/029062Dr Mayoori
尚未招募
不适用
To study effect of ayurvedic treatment for prevention and management of asymptomatic, mild and moderate cases of COVID-19.CTRI/2020/06/026231Ministry of AYUSH